Treatment of resectable gallbladder cancer
Simple Summary Gallbladder cancer (GBC) is the most common biliary tract cancer
worldwide, with incidental GBC being the most common presentation of resectable …
worldwide, with incidental GBC being the most common presentation of resectable …
Contrast-enhanced CT radiomics for prediction of recurrence-free survival in gallbladder carcinoma after surgical resection
F Xiang, X Liang, L Yang, X Liu, S Yan - European Radiology, 2022 - Springer
Objectives Gallbladder carcinoma (GBC) is the most common and aggressive biliary tract
malignancy with high postoperative recurrence rates. This single-center study aimed to …
malignancy with high postoperative recurrence rates. This single-center study aimed to …
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents …
M Niger, F Nichetti, L Fornaro, C Pircher, F Morano… - BMC cancer, 2024 - Springer
Abstract Background Biliary tract cancers (BTCs) are rare and lethal cancers, with a 5-year
survival inferior to 20%(1–3). The only potential curative treatment is surgical resection …
survival inferior to 20%(1–3). The only potential curative treatment is surgical resection …
Application of hazard function to investigate recurrence of intrahepatic cholangiocarcinoma after curative-intent liver resection: a novel approach to characterize …
Purpose To investigate recurrence patterns after surgery for intrahepatic
cholangiocarcinoma (ICC) relative to lymph node status, tumor extension, tumor burden …
cholangiocarcinoma (ICC) relative to lymph node status, tumor extension, tumor burden …
Lymphadenectomy in gallbladder adenocarcinoma: Are we doing enough?
MV Papageorge, SWL de Geus, AP Woods… - The American Journal of …, 2022 - Elsevier
Background Current AJCC guidelines recommend evaluating≥ 6 lymph nodes during
gallbladder cancer resection but real world data suggest this is rarely achieved. We …
gallbladder cancer resection but real world data suggest this is rarely achieved. We …
High-quality surgery for gallbladder carcinoma: rare, associated with disparity, and not substitutable by chemotherapy
Background Oncologic surgery for T1b-T3 gallbladder carcinoma (GBC) consists of
gallbladder fossa resection or bisegmentectomy IVb/V with negative margins and …
gallbladder fossa resection or bisegmentectomy IVb/V with negative margins and …
Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma
D Bekric, ML Tornesello, M Ocker, C Mayr… - Frontiers in Cell and …, 2023 - frontiersin.org
Background Hepatocellular carcinoma (HCC) and biliary tract cancers (BTC) represent the
two major forms of primary liver cancers. Despite the growing efforts to translate the …
two major forms of primary liver cancers. Despite the growing efforts to translate the …
Preoperative immunological plasma markers TRAIL, CSF1 and TIE2 predict survival after resection for biliary tract cancer
Introduction Systemic inflammatory markers have been validated as prognostic factors for
patients with biliary tract cancer (BTC). The aim of this study was to evaluate specific …
patients with biliary tract cancer (BTC). The aim of this study was to evaluate specific …
[HTML][HTML] Comparison of the clinical features and long-term prognosis of gallbladder neuroendocrine carcinoma versus gallbladder adenocarcinoma: A propensity …
YF Hu, WJ Ma, HJ Hu, HF Gu, YW Jin… - Biomolecules and …, 2023 - ncbi.nlm.nih.gov
Gallbladder neuroendocrine carcinoma (GBNEC) is rare and characterized by a low degree
of tumor differentiation. The clinical features of GBNEC versus gallbladder adenocarcinoma …
of tumor differentiation. The clinical features of GBNEC versus gallbladder adenocarcinoma …
Predicting recurrence patterns following curative-intent resection for intrahepatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma (ICC), based on margin status alone following a curative-
intent resection, has a 5-year overall survival ranging between 4.7%(R1) to 39.8%(R0). 1 …
intent resection, has a 5-year overall survival ranging between 4.7%(R1) to 39.8%(R0). 1 …